An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.
about
Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.A Strategy to Delay the Development of Cisplatin Resistance by Maintaining a Certain Amount of Cisplatin-Sensitive Cells.Glucose deprivation elicits phenotypic plasticity via ZEB1-mediated expression of NNMT.Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)IAP antagonists Birinapant and AT-406 efficiently synergise with either TRAIL, BRAF, or BCL-2 inhibitors to sensitise BRAFV600E colorectal tumour cells to apoptosis.Claudin-4 activity in ovarian tumor cell apoptosis resistance and migrationComprehensive discovery of subsample gene expression components by information explanation: therapeutic implications in cancer.A Designed Inhibitor of p53 Aggregation Rescues p53 Tumor Suppression in Ovarian CarcinomasCisplatin induces stemness in ovarian cancer.AT101 exerts a synergetic efficacy in gastric cancer patients with 5-FU based treatment through promoting apoptosis and autophagy.Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian CancerSystems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response.Recently identified drug resistance biomarkers in ovarian cancer.Inhibition of endoplasmic reticulum (ER) stress sensors sensitizes cancer stem-like cells to ER stress-mediated apoptosisBivalent IAP antagonists inhibit TRAF2-bound cIAPs and limit TNF-mediated NF-κB signalingXIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy.Mutagenic assessment of chemotherapy and Smac mimetic drugs in cells with defective DNA damage response pathways
P2860
Q33632016-D4F1BD8E-68D1-4683-9BC8-822A2A6D26DAQ33671792-E8DD5EFE-B895-43DD-9563-0C736FEA26FAQ33688593-B9131F11-E6A1-447E-989D-196DEAEFEBDFQ33841579-258E78EC-8233-4C2D-8822-53D00903C5ADQ36103378-A49A7045-D666-4735-9D6A-C638C1046A75Q36159864-A043EE3C-8311-4251-8E4C-FCBAD4ADAC4CQ36307837-88DA35BC-CACD-470C-89F2-4DB6965BCD3BQ36521889-4FA32BB0-DC8D-4F58-84F8-533F104FAEE5Q37327524-73042F2C-A0C1-481C-A6D5-C9270BBEB2ECQ37376289-4A2AF2CF-6404-48BB-87D6-BD4D67371572Q37510221-126F7377-B51F-41E8-991C-1C9830B3F09EQ38605020-11576848-014C-4F2A-B8E5-E3CAC46F328DQ38741073-E402D6EB-9187-4312-A71A-C6D6AD79C498Q38763356-CDC6838B-2742-4163-A6B8-2539D425C886Q41432435-A9E2B2F9-2659-47CD-B672-2BA406EDBCC7Q52647668-4AC02AA7-9111-4D9E-8186-42D897BF764BQ52649982-755D0D0C-E075-49B9-A201-2DC57C913217Q53499541-A8F46F23-5B40-4150-8092-A312928B61CBQ58695632-9BF78072-4BBA-4A5A-8FF5-A709402DCD71
P2860
An apoptosis-enhancing drug overcomes platinum resistance in a tumour-initiating subpopulation of ovarian cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
An apoptosis-enhancing drug ov ...... bpopulation of ovarian cancer.
@ast
An apoptosis-enhancing drug ov ...... bpopulation of ovarian cancer.
@en
type
label
An apoptosis-enhancing drug ov ...... bpopulation of ovarian cancer.
@ast
An apoptosis-enhancing drug ov ...... bpopulation of ovarian cancer.
@en
prefLabel
An apoptosis-enhancing drug ov ...... bpopulation of ovarian cancer.
@ast
An apoptosis-enhancing drug ov ...... bpopulation of ovarian cancer.
@en
P2093
P2860
P356
P1476
An apoptosis-enhancing drug ov ...... bpopulation of ovarian cancer.
@en
P2093
P2860
P2888
P356
10.1038/NCOMMS8956
P407
P577
2015-08-03T00:00:00Z